GRIN3B
Basic information
Region (hg38): 19:1000419-1009732
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GRIN3B gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 106 | 113 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 106 | 5 | 7 |
Variants in GRIN3B
This is a list of pathogenic ClinVar variants found in the GRIN3B region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-1000421-A-G | Benign (Oct 09, 2018) | |||
19-1000525-C-G | not specified | Uncertain significance (Sep 27, 2021) | ||
19-1000567-C-T | not specified | Uncertain significance (Oct 13, 2021) | ||
19-1000585-C-T | not specified | Uncertain significance (Jun 16, 2022) | ||
19-1000601-C-T | not specified | Uncertain significance (Sep 07, 2022) | ||
19-1000613-G-A | not specified | Uncertain significance (Jul 12, 2023) | ||
19-1000645-C-G | not specified | Uncertain significance (Mar 16, 2024) | ||
19-1000649-G-T | not specified | Uncertain significance (Dec 18, 2023) | ||
19-1000677-C-A | Likely benign (Mar 01, 2022) | |||
19-1000682-G-A | not specified | Uncertain significance (Oct 05, 2021) | ||
19-1000690-G-A | not specified | Uncertain significance (Jan 23, 2023) | ||
19-1000702-C-G | not specified | Uncertain significance (Mar 15, 2024) | ||
19-1000778-T-C | not specified | Uncertain significance (Nov 28, 2023) | ||
19-1000786-C-T | Benign (Mar 25, 2019) | |||
19-1000787-A-T | not specified | Uncertain significance (Feb 28, 2023) | ||
19-1000804-A-G | not specified | Uncertain significance (Nov 22, 2021) | ||
19-1000859-C-T | not specified | Uncertain significance (Jun 16, 2024) | ||
19-1003142-C-G | not specified | Uncertain significance (Jan 02, 2024) | ||
19-1003179-T-C | not specified | Uncertain significance (Apr 17, 2024) | ||
19-1003223-G-C | not specified | Uncertain significance (Feb 06, 2023) | ||
19-1003322-C-T | not specified | Uncertain significance (Feb 10, 2022) | ||
19-1003325-C-T | not specified | Uncertain significance (Feb 10, 2022) | ||
19-1003350-G-A | not specified | Likely benign (Aug 08, 2022) | ||
19-1003365-C-T | not specified | Uncertain significance (Jan 19, 2024) | ||
19-1003371-C-T | not specified | Uncertain significance (Jan 10, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GRIN3B | protein_coding | protein_coding | ENST00000234389 | 9 | 9314 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.02e-7 | 0.887 | 72506 | 8221 | 44938 | 125665 | 0.240 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.03 | 632 | 563 | 1.12 | 0.0000432 | 6347 |
Missense in Polyphen | 228 | 195.72 | 1.1649 | 2043 | ||
Synonymous | -1.69 | 307 | 271 | 1.13 | 0.0000223 | 2347 |
Loss of Function | 1.64 | 14 | 22.4 | 0.625 | 0.00000109 | 258 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.439 | 0.433 |
Ashkenazi Jewish | 0.295 | 0.288 |
East Asian | 0.0669 | 0.0643 |
Finnish | 0.310 | 0.297 |
European (Non-Finnish) | 0.301 | 0.287 |
Middle Eastern | 0.0669 | 0.0643 |
South Asian | 0.196 | 0.192 |
Other | 0.266 | 0.255 |
dbNSFP
Source:
- Function
- FUNCTION: NMDA receptor subtype of glutamate-gated ion channels with reduced single-channel conductance, low calcium permeability and low voltage-dependent sensitivity to magnesium. Mediated by glycine.;
- Pathway
- Glutamatergic synapse - Homo sapiens (human);Nicotine addiction - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Amphetamine addiction - Homo sapiens (human);Neuroactive ligand-receptor interaction - Homo sapiens (human);Alcoholism - Homo sapiens (human);Cocaine addiction - Homo sapiens (human)
(Consensus)
Haploinsufficiency Scores
- pHI
- 0.0563
- hipred
- N
- hipred_score
- 0.472
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.833
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Grin3b
- Phenotype
- growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- ionotropic glutamate receptor signaling pathway;protein insertion into membrane;regulation of calcium ion transport;calcium ion transmembrane transport
- Cellular component
- plasma membrane;NMDA selective glutamate receptor complex;cell junction;neuronal cell body;postsynaptic membrane
- Molecular function
- ionotropic glutamate receptor activity;cation channel activity;calcium channel activity;glycine binding;neurotransmitter receptor activity;neurotransmitter binding